Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|1|40-46

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.1, 2015-07, pp. : 40-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 730-737

John Wiley & Sons Inc

Access to resources Recommend Favorite

The long‐term effects of anti‐TNF‐α agents on patients with chronic viral hepatitis C and B infections

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 1, 2015-01 ,pp. : 40-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sustained Negativity for HCV-RNA over 24 or More Months by Long-Term Interferon Therapy Correlates with Eradication of HCV in Patients with Hepatitis C Virus Genotype 1b and High Viral Load

By  

Intervirology, Vol. 47, Iss. 1, 2004-03 ,pp. : 19-25

Karger

Access to resources Recommend Favorite

Long‐term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 84-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects

By  

HEPATOLOGY, Vol. 62, Iss. 3, 2015-09 ,pp. : 684-693

John Wiley & Sons Inc

Access to resources Recommend Favorite